| Bringing business risk into sharp focus Comprehensive due diligence on research constraints, regulatory and reimbursement barriers, as well as patient and physician preferences is important to increase the chances of success for a life science business. | |||
| Planning for the exit As the biotech industry has matured, the exit process has evolved. Entrepreneurs need to build today's companies based on the new exit paradigm. View more articles | |||
Also visit the Bioentrepreneur portal http://www.nature.com/bioent/ for an update on the latest events focusing on life science entrepreneurship around the world. | |||
| | |||
| An ongoing audio series hosted by Nature Biotechnology, in which authors of our articles discuss practical advice and guidance, acquired from their experience in the biotech industry. View authors | |||
| | |||
| The Bioentrepreneur blog, Trade Secrets, boasts contributors from around the globe, providing regular insight and commentary from those helping build the world's biotechnology sectors. | |||
| | |||
| Video presentations offering career advice in the biosciences. Brought to you by Naturejobs and Stanford School of Medicine Career Center. | |||
Advertisement | |||
| |||
| |||
Thursday, January 5, 2012
Bioentrepreneur Contents: December 2011/January 2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment